Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Public ClinicalTrials.gov record NCT02428660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Medication Therapy Management Combined With Drug and Gene Interaction Software and Cytochrome DNA Testing Among a Population of Polypharmacy Medicare Patients
Study identification
- NCT ID
- NCT02428660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Genelex Corporation
- Industry
- Enrollment
- 341 participants
Conditions and interventions
Conditions
- Cytochrome P450 CYP2D6 Enzyme Deficiency
- Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
- Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant
- Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant
- Cytochrome P450 CYP2C9 Enzyme Deficiency
- Cytochrome P450 CYP2C19 Enzyme Deficiency
- Drug Metabolism, Poor, CYP2D6-RELATED
- Drug Metabolism, Poor, CYP2C19-RELATED
- CYP2D6 Polymorphism
Interventions
- Pharmacogenetic testing Genetic
- Software-based drug & gene interaction risk analysis Other
- MTM Other
Genetic · Other
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Jan 31, 2017
- Completion
- Jan 31, 2017
- Last update posted
- Feb 22, 2017
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VRx Pharmacy Services | Salt Lake City | Utah | 84109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02428660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02428660 live on ClinicalTrials.gov.